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Abstract
Background We report striking and unanticipated
improvements in maladaptive behaviours in Prader–
Willi syndrome (PWS) during a trial of vagus nerve
stimulation (VNS) initially designed to investigate
effects on the overeating behaviour. PWS is a geneti-
cally determined neurodevelopmental disorder asso-
ciated with mild–moderate intellectual disability (ID)
and social and behavioural difﬁculties, alongside a
characteristic and severe hyperphagia.
Methods Three individuals with PWS underwent
surgery to implant the VNS device. VNS was
switched on 3months post-implantation, with an ini-
tial 0.25mA output current incrementally increased
to a maximum of 1.5mA as tolerated by each indi-
vidual. Participants were followed up monthly.
Results Vagal nerve stimulation in these individuals
with PWS, within the stimulation parameters used here,
was safe and acceptable. However, changes in eating
behaviour were equivocal. Intriguingly, unanticipated,
although consistent, beneﬁcial effects were reported by
two participants and their carers in maladaptive
behaviour, temperament and social functioning. These
improvements and associated effects on food-seeking
behaviour, but not weight, indicate that VNS may have
potential as a novel treatment for such behaviours.
Conclusions We propose that these changes are
mediated through afferent and efferent vagal
projections and their effects on speciﬁc neural
networks and functioning of the autonomic nervous
system and provide new insights into the mechanisms
that underpin what are serious and common
problems affecting people with IDs more generally.
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Introduction
Prader–Willi syndrome (PWS) is a
neurodevelopmental disorder arising from a lack of
expression of maternally imprinted genes at
chromosomal locus 15q11–13. PWS affects around 1 in
25000–29000 births (Whittington et al. 2001; Smith
et al. 2003) and is associated with mild–moderate
intellectual disability; low muscle tone; early failure to
thrive; relative growth and sex hormone deﬁciencies;
behavioural, social and psychiatric difﬁculties,
including temper outbursts, need for routine, skin
picking, repetitive and ritualistic behaviours, and poor
social adjustment and severe overeating beginning in
preschool years, which, if unchecked, is responsible
for increased mortality (Holland et al. 2003;
Schrander-Stumpel et al. 2003; Stevenson et al. 2007).
This overeating appears to result from aberrant
satiety signalling, with both behavioural and
neuroimaging studies demonstrating that satiety
responses are delayed and short-lived in PWS
but, crucially, are present and potentially malleable
(e.g.Holland et al. 1993;Hinton et al. 2006).No effective
treatments for overeating are presently available.
Vagus nerve stimulation therapy® (VNS;
Cyberonics, TX, USA) is approved for the treatment of
epilepsy anddepression.A small device implanted in the
upper chest stimulates the left vagus nerve via electrodes
attached to the nerve in the neck. The vagus nerve is
involved in satiety signals from the gastrointestinal
system to the brain, and studies have reported weight
loss in some patients undergoing VNS, as well as altered
food cravings (Burneo et al. 2002; Bogacz & Asconape
2003; Roslin & Kurian 2003; Koren & Holmes 2006;
Bodenlos et al. 2007; Pardo et al. 2007; Abubakr &
Wambucq 2008; Kansagra et al. 2010), indicating
potential utility of VNS for use in the obese population.
Although the overeating often severely limits
independence, for many individuals with PWS and
those who support them, once a system for
controlling food intake has been established, some of
the biggest daily difﬁculties arise from the wider
maladaptive behaviours common to people with PWS.
Around 70% of those with PWS are reported to show
marked behavioural problems (Holland et al. 2003).
Maladaptive behaviours may be exhibited in relation
to food seeking; however, such behaviours extend
beyond the food-related problems to a more general
difﬁculty with mood lability and changes to routines
and expectations that can escalate from repetitive
questioning to physically aggressive outbursts.
The initial aim of this study was to assess the safety,
acceptability and efﬁcacy of VNS as a novel treatment
for hyperphagia in PWS. However, unexpected
improvements in the rate and severity of maladaptive
behaviours were spontaneously reported by two
participants and their families (see succeeding text).
Consequently, the study took on a new aim: that of
investigating potential effects of VNS on maladaptive
behaviours.
Method
Participants
Ethical review and approval was obtained from the
Cambridgeshire 1 Ethics Committee. Three adults
(one man and two women; aged 20, 23 and 28 years at
implantation) with genetically conﬁrmed PWS, body
mass index> 30 and the capacity to consent were
recruited to the study via the Prader–Willi Syndrome
Association UK.
Procedure
The VNS therapy system was surgically implanted
under general anaesthetic beneath the left clavicle
(Cyberonics model 102 generator), and electrodes
were attached to the left vagus nerve (Cyberonics
model 302 bipolar lead) according to standard
practice (Landy et al. 1993).
Before VNS activation, participants attended three
monthly overnight visits at the National Institute for
Health Research/Wellcome Trust Clinical Research
Facility, Cambridge, for baseline measurements of
the initial outcome variables. VNS was switched on
with the following initial stimulation settings: 0.25mA
output current, 30Hz frequency, 500 μsec pulse width
and a 30 s on-time, 5min off-time cycle. Following
activation, participants continued to attend monthly
overnight visits at the Clinical Research Facility,
where the VNS output current was increased in
0.25mA steps to a maximum of 1.5mA as tolerated by
each individual, and outcome measures to assess
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safety, acceptability and efﬁcacy were obtained. Visit
frequency was reduced to bimonthly once established
on the maximum output.
Measures of efﬁcacy and mechanism
Weight and body composition were measured using
air-displacement plethysmography (BOD POD; Life
Measurement, Inc., CA, USA). The quantity
consumed during 1-h free access to food with
homogenous calorie content was recorded using a
universal eating monitor (Sussex Ingestion Pattern
Monitor, University of Sussex). The hospital anxiety
and depression scale was administered to assess
potential additional effects on mood (Zigmond &
Snaith 1983).
Additional measures
Semi-structured interviews were carried out with each
participant and carer to characterise the unexpected
spontaneous reports of marked, positive behavioural
changes. These were analysed by an independent
researcher using thematic analysis (Braun & Clarke
2008).
Daily observation records were also obtained for
one participant from her residential college, covering
the academic year prior to starting VNS and two
terms of the academic year following VNS initiation.
Records for the intervening academic year, during
VNS activation and intensity increase, were
unavailable. These narrative accounts were studied
for evidence of behavioural changes following VNS
using directed qualitative content analysis (Hsieh &
Shannon 2005), with coding categories informed by
the themes emerging from the interviews and
determined by the data available. Mean occurrences
per half term before and with VNS were calculated for
each coded behaviour.
Measures of safety and acceptability
Owing to the reported association of VNS with
increases in sleep apnoea (Marzec et al. 2003), sleep
was monitored to ensure safety in respect to sleep
apnoea using a SomnoscreenTM plus RC system
(SOMNOmedics, Germany) approximately every
3months, with overnight oximetry at other visits.
Heart rate and blood pressure were monitored during
and for 4h following VNS switch on and intensity
increases, with pulse rate monitoring continuing
throughout the night.
Results
Efﬁcacy
Weight and body composition
Following VNS implantation, but prior to activation
in January 2010, participant 1 started to gain weight,
leading to cessation of VNS approximately 8months
after activation. VNS was reinstated 5months later at
the participant’s request. Her weight remained
elevated (at around 15–20 kg above baseline), but
more stable. VNS was switched off at study
conclusion in September 2012.
Participant 2 has had ongoing stimulation since
February 2010, with no reported side effects. Her
weight remained stable for the ﬁrst 8months of
stimulation and, thereafter, showed a small and
gradual decrease with some ﬂuctuations. At study
conclusion, his weight was 2.6 kg (2.9%) below his or
her mean baseline weight of 90.4 kg, accounted for by
loss of body fat alongside increased lean mass. Poor
glycaemic control with energy loss from glucosuria
may have contributed.
Participant 3 started VNS in February 2011. Her
weight remained stable, with small ﬂuctuations.
Data are available on request.
Eating behaviour
Changes in everyday eating behaviour have been
observed in two participants. Participants 2 and 3 and
their respective carers reported occasions when they
have been amenable to unexpected alterations to food
routine, including missing meals. Such tolerance was
never experienced prior to VNS. For participant 3,
this has extended to voluntarily taking less than
allowed at some mealtimes, corroborated by college
records indicating an increase in instances of leaving
food offered or taking less than allowed (Fig. 1).
Participant 3 also reported decreased attempts to
obtain or conceal extra food, supported by a
reduction of reports of food-seeking behaviour in her
college records (Fig. 1). However, no participant
showed a consistent reduction in quantity consumed
during 1-h ad libitum access to food under
experimental conditions (data not shown).
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Unexpected observations of behaviour and temperament
change
Six organising themes emerged from semi-structured
interviews carried out to explore reports of positive
effects on temperament, behaviour and social
functioning: ‘unpredictability and cognitive
inﬂexibility’, ‘volatile social relationships’,
‘controlling power of food’, ‘controlled mood and
ﬂexibility of thought’, ‘increased ability to interact
socially’ and ‘freedom from food focus’ (Table 1).
Two participants and two carers reported
improvements in the behaviour and temperament of
the individual with PWS. These improvements were
demonstrated through changes in the three
superordinate themes, ‘reactivity’, ‘social functioning’
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Figure 1 Mean incidence of behaviours per half term before and during vagal nerve stimulation (VNS) as reported in participant 3’s daily
observation records kept by the residential college at which he or she was a resident student.
Table 1 Thematic analysis of semi-structured interviews exploring reported behavioural improvements
VNS status Superordinate theme Organising theme Code
Before VNS Reactivity Unpredictability and
cognitive inﬂexibility
Mood lability; inﬂexibility;
frequent temper outbursts
Social functioning Volatile social relationships Difﬁculty in social situations;
family dysfunction
Control over food Controlling power of food Ruled by food; stressful impact
on carer’s daily life/routine
With VNS Reactivity Controlled mood and
ﬂexibility of thought
Infrequent temper outbursts;
calm/happier mood; low anxiety;
increased ﬂexibility of thought/ability
to reason; sense of well-being
Social functioning Increased ability to
interact socially
Coping in social situations; enhanced
family functioning
Control over food Freedom from food
focus
Liberating effect of VNS; lower focus
on food; slight lessening of hunger;
improved carer’s mood
VNS, vagal nerve stimulation.
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and ‘control over food’, into which the six organising
themes could be grouped, with each superordinate
theme comprising one organising theme relating to
life before VNS and another to life with VNS
(Table 1). Overall, increased emotional and cognitive
ﬂexibility was described, enabling better handling of
situations that would previously have caused a temper
outburst, including changes to routines and
expectations, with beneﬁcial consequences for family
life and social functioning.
No such changes were reported by participant 1
and her carer. However, participant 1 did not
experience the same level of behavioural difﬁculties
prior to VNS.
Analysis of participant 3’s college records suggested
reduced rigidity, better appreciation of alternative
perspectives, reduced food focus (especially food
seeking), generally increased food freedom
(particularly consuming less than allowed) and reduced
temper outbursts and outburst-associated behaviours
with VNS (Fig. 1). Only two sub-codes did not ﬁt this
pattern of improvement andwere related to instances of
coping well with expectation change. While these
appear to question improvement in this area, negative
instances of this behaviour (i.e. demonstrating need for
routine) were reduced.
For all participants, hospital anxiety and depression
scale scores remained low throughout the study (data
not shown), suggesting improvements could not be
simply be explained by the alleviation of previously
undiagnosed depressive mood.
Safety and acceptability
Participant self-reports suggested few side effects of
VNS; two participants experienced voice hoarseness
during stimulation, but this was well tolerated.
Few safety concerns arose. An increase in
obstructive events in participant 1’s pre-existing
obstructive sleep apnoea resolved with alteration of
established continuous positive airway pressure
settings. This increase corresponded to participant 1’s
weight gain, suggesting that it was not directly VNS
related.
Participant 3 reported dyspnoea during physical
exertion following VNS output reaching 1.0mA. VNS
was temporarily ceased, but comprehensive tests of
lung function found no detrimental effects of VNS on
respiration, and stimulation was reinstated 1month
later with no re-emergence of symptoms. This is a
commonly reported side effect of VNS and is not
thought to present any danger (Handforth et al. 1998).
Discussion
The initial aims of this study were to investigate the
safety and acceptability of VNS in adults with PWS
and its possible efﬁcacy in reducing hyperphagia.
Other than tolerable effects on voice, no side effects or
signiﬁcant safety issues were found. VNS had no
direct effect on reducing food intake, and only one
participant showed minimal weight loss. There were,
however, unexpected clinically signiﬁcant emotional
and behavioural beneﬁts of VNS in the two
participants who had previously shown signiﬁcant
problems in these areas. Improvements in ﬂexibility
around food routine and food-seeking behaviour were
associated with reduced temper outbursts and
difﬁcult behaviour when mealtimes were
unexpectedly postponed or a desired food was
denied. Furthermore, these changes extended beyond
food-related events to other situations that would
previously have resulted in difﬁcult behaviour.
The observed effects were sufﬁcient to lead to
spontaneous and independent reports by family and
to the request for continuation of VNS therapy
despite the absence of signiﬁcant weight loss. As these
behavioural effects were not anticipated, quantitative
prestimulation behavioural data were unavailable.
However, the reported changes were largely
corroborated by participant 3’s college records.
Despite clear limitations, these documents provide a
valuable record of behaviour both prior to and during
a period of VNS, written contemporaneously by
carers independent of the research study.
Conclusions are also limited by the small number
of participants and non-random selection – a result of
the invasive nature of the intervention and the
uncertainty of outcome – and the lack of prospective
measures to assess these serendipitous ﬁndings.
Furthermore, blinding was not possible, owing to the
need to ensure participant safety during this novel
treatment in PWS, as well as noticeable effects on the
voice during stimulation. However, it appears unlikely
that improvements arose because of non-treatment
study-related factors, such as expectation, attention
and feedback, given that the reported improvements
were largely unanticipated in nature and intensive
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monitoring had been in place for a number of months
prior to VNS activation without such changes
occurring. Moreover, such factors did not enable a
reduction in food intake during even a short hour-
long food test.
Effects on behaviour and social and cognitive
functioning have previously been identiﬁed in the
VNS literatures potentially independent from the
effects of VNS on seizure control (e.g. Rawlins 1997;
Galli et al. 2003; Kossoff & Pyzik 2004; Cukiert et al.
2009; Alonso-Vanegas et al. 2010; Achinivu et al.
2012). Importantly, the current study provides
evidence for improvements in global functioning with
VNS in individuals whose psychobehavioural
symptoms are not secondary to depression or
seizures. This suggests that behavioural beneﬁts of
VNS can be independent from its anticonvulsant and
antidepressant effects.
We propose that these incidental observations
indicate the possibility that the predisposition to such
maladaptive behaviours has a biological basis
mediated on the basis of the inﬂuence of afferent and
efferent vagal projections on speciﬁc neural networks
and functioning of the autonomic nervous system (in
line with Porges’s polyvagal theory; Porges & Furman
2011).
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